期刊文献+

金属硫蛋白2A基因-838G/C多态性与冠心病的关联研究 被引量:2

Study on the association of-838G/C polymorphism in the metallothionein 2A gene with coronary heart disease
原文传递
导出
摘要 目的:研究中国江苏汉族人群金属硫蛋白2A(Metallothionein2A,MT2A)基因-838G/C多态性与冠心病的关联性。方法:采用单荧光标记探针技术,检测287例冠心病患者和226例健康对照者的MT2A基因-838G/C多态性。结果:MT2A基因-838G/C多态性基因型和等位基因频率分布在冠心病组和对照组比较差异有统计学意义(P<0.05)。冠心病组MT2A-838C等位基因频率明显高于对照组(31.4%∶24.6%,P=0.016),C等位基因携带者(GC+CC基因型)患冠心病的风险是GG基因型的1.562倍(OR=1.562,95%CI:1.099~2.218,P=0.013),Logistic回归分析显示,携带C等位基因是冠心病的独立危险因素(P<0.05)。冠心病组C等位基因携带者的冠状动脉Gensini积分明显高于非C等位基因携带者(P<0.05)。结论:MT2A基因-838G/C多态性与中国江苏汉族人群冠心病的发生有关联,C等位基因可能是冠心病发病的遗传易感基因,并影响冠状动脉病变的严重程度。 Objective:To investigate the association between the --838G/C polymorphism in the metallothio nein 2A(MT2A ) gene and coronary heart disease(CHD) in Chinese Han population of Jiangsu. Method:The gen otypes of --838G/C polymorphism in the MT2A gene were detected by single labeled probe technique in 287 CHD patients and 226 healthy controls. Results:There was a significant difference in frequencies of genotype and allele in --838G/C polymorphism between CHD and control group respectively(P〈0.05). The frequency of the 838C allele in the patients with CHD group was significantly higher than that in the control group (31.4% vs 24.6%,P=0. 016). The relative risk of suffering from CHD with C allele carriers(GC+CC genotype) was 1. 562 times higher than those with GG genotype (OR =1. 562,95 % C1 : 1. 099-2.218, P=0.013). Logistic regression analysis found that carrying C allele was an independent risk factor of CHD(P〈0.05). Compared with non- C allele carriers, C allele carriers had significantly higher Gensini's coronary score in the CHD group(P〈0.05). Conclusion:The MT2A--838G/C polymorphism is associated with CHD in Chinese Han population of Jiangsu. C allele may be one of the genetic susceptible gene for CHD and may influent on the severity of coronary stenosis.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2009年第12期929-932,共4页 Journal of Clinical Cardiology
基金 常州市卫生局重大招标项目(No:ZD200709)
关键词 冠状动脉疾病 金属硫蛋白 多态性 单核苷酸 coronary disease metallothionein potymorphism single nucleotide
  • 相关文献

参考文献14

  • 1KANG Y J. The antioxidant function of metallothionein in the heart[J]. Proc Soc Exp Biol Med, 1999, 222:263-273.
  • 2GOBEL H, VAN DER WAL A C, TEELING P, et al. Metallothionein in human atherosclerotic lesions: a scavenger mechanism for reactive oxygen species in the plaque? [J].Virehows Arch, 2000, 437:528 -533.
  • 3WU M T, DEMPLE B, BENNETT R A, et al. Indi vidual variability in the zinc inducibility of metallothionein-IIA mRNA in human lymphocytes[J].J Toxicol Environ Health A, 2000, 61:553-567.
  • 4罗光华,郑璐,张晓膺,许国锋,朱江,牟琴峰,魏江,陈陆俊,张俊,徐宁.ShineRoar探针技术检测单核苷酸多态性[J].中华检验医学杂志,2007,30(6):609-612. 被引量:8
  • 5LUOG,ZHENG L,ZHANG X,et al. Genotyping of single nucleotide polymorphismsusing base quenched probe: A method does not invariably depend on the deoxyguanosine nucleotide[J]. Anal Biochem, 2009, 386:161-166.
  • 6GENSINI G G. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol,1983,51 :606-606.
  • 7MARET W. Zinc coordination environments in proteins as redox sensors and signal transducers[J]. Antioxid RedoxSignal, 2006, 8:1419 -1441.
  • 8BEATTIE J H, KWUN I S. Is zinc deficiency a risk factor for atherosclerosis? [J].Br J Nutr, 2004, 91:177- 181.
  • 9MOCCHEGIANI E, GIACCONI R, CIPRIANO C, et al. MtmRNA gene expression, via IL-6 and glucocortieoids, as potential genetic marker of imrnunosenescence: lessons from very old mice and humans[J].Exp Gerontol, 2002, 37:349-357.
  • 10GIACCONI R, BONFIGLI A R, TESTA R, et al. +647 A/C and + 1245 MTIA polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complieations[J]. Mol Genet Metab, 2008, 94: 98- 104.

二级参考文献20

  • 1Rudi K, Holck AL. Real-time closed tube single nucleotide polymorphism (SNP) quantitlcation in pooled samples by quencher extension ( QEXT ). Nucleic Acids Res, 2003,31 : e117.
  • 2Sollnas A, Brown I.J, McKeen C, et al. Duplex Scorpion primers in SNP analysis and FRET applications. Nucleic Acids Res, 2001,29 : E96.
  • 3Rao KV, Stevens PW, Hall JG, et al. C, enotyping single nucleotide polymorphisms directly from genomlc DNA by invasive cleavage reaction on microspheres. Nucleic Acids Res, 2003, 31 : e66.
  • 4Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res, 1998,8 : 1229-1231.
  • 5Carlson CS, Newman TL, Nickerson DA. SNPing in the human genome. Curr Opin Chem Biol, 2001,5:78-85.
  • 6Ergen E, Weber M, Jacob J, et al. Twin probes as a novel tool for the detection of single-nucleotide polymorphisms. Chemistry, 2006,12:3707-3713.
  • 7Beltinger CP, White PS, Maris JM, et al. Physical mapping and genomic structure of the human TNFR2 gene. Genomics, 1996, 35:94-100.
  • 8Komata T, Tsuchiya N,. Matsushita M, et al. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens, 1999,53:527-533.
  • 9Barton A, John S, Oilier WE, et al. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor Ⅱ, but not tumor necrosis factor receptor Ⅰ, in Caucasians. Arthritis Rheum, 2001,44:61-65.
  • 10Xu N, Dahlback B. A novel human apolipoprotein ( apoM ). J Biol Chem, 1999, 274:31286-31290.

共引文献7

同被引文献15

  • 1UNGER E,METZGER P,KRUPINSKI E,et al.The use of a thrombus-specific ultrasound contrast agent to detect thrombus inarteriovenous fistulae[J].Invest Radiol,2000,35:86-89.
  • 2PIETERS M,HEKKENBERG R T,BARRETTBERGSHOEFF M,et al.The effect of 40 kHz ultrasound on tissue plasminogen activator-induced clot lysis in three in vitro models[J].Ultrasound Med Biol,2004,30:1545-1552.
  • 3Dziegiel P,Jelen M,Muszczynska B. Role of metallothionein expression in non-small cell lung carcinomas[J].{H}Roczniki Akademii Medycznej W Bialymstoku,2004,(Suppl 1):43-45.
  • 4Mendez-Armenta M,Villeda-Hernandez J,Barroso-Moguel R. Brain regional lipid peroxidation and metallothionein levels of developing rats exposed to cadmium and dexamethasone[J].{H}Toxicology Letters,2003,(02):151-157.
  • 5Krzeslak A,Forma E,Jozwiak P. Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer[J].{H}Clinical and Experimental Medicine,2012.
  • 6Luo G,Zheng L,Zhang X. Genotyping of single nucleotide polymorphisms using base-quenched probe:a method does not invariably depend on the deoxyguanosine nucleotide[J].{H}Analytical Biochemistry,2009,(02):161-166.
  • 7Steinmetz OM,Panzer U,Harendza S. No association of the-2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy[J].{H}Nephrology Dialysis Transplantation,2004,(03):596-601.
  • 8Gruber HE,Hoelscher G,Ingram JA. 1,25(OH) 2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1,thrombopoietin,VEGF,and angiogenin by human annulus cells in vitro[J].Spine (Phila Pa 1976),2008,(07):755-765.
  • 9Karrer S,Bosserhoff AK,Weiderer P. The-2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis[J].{H}Journal of Investigative Dermatology,2005,(01):92-98.
  • 10Szalai C,Duba J,Prohaszka Z. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD).Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients[J].{H}ATHEROSCLEROSIS,2001,(01):233-239.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部